GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Syneos Health Inc (NAS:SYNH) » Definitions » Owner Earnings per Share (TTM)

Syneos Health (Syneos Health) Owner Earnings per Share (TTM) : 0.96 (As of Jun. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Syneos Health Owner Earnings per Share (TTM)?

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Syneos Health's Owner Earnings per Share (TTM) ended in Jun. 2023 was $0.96. It's Price-to-Owner-Earnings ratio for today is 44.77.


The historical rank and industry rank for Syneos Health's Owner Earnings per Share (TTM) or its related term are showing as below:

SYNH' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 8.04   Med: 24.51   Max: 707.46
Current: 39.06


During the past 12 years, the highest Price-to-Owner-Earnings ratio of Syneos Health was 707.46. The lowest was 8.04. And the median was 24.51.


SYNH's Price-to-Owner-Earnings is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 25.185 vs SYNH: 39.06

Syneos Health's Earnings per Share (Diluted) for the three months ended in Jun. 2023 was $0.01. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $0.69. It's PE Ratio ratio for today is 62.29.

Syneos Health's EPS without NRI for the three months ended in Jun. 2023 was $0.10. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2023 was $2.22. It's PE Ratio without NRI ratio for today is 19.33.


Syneos Health Owner Earnings per Share (TTM) Historical Data

The historical data trend for Syneos Health's Owner Earnings per Share (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syneos Health Owner Earnings per Share (TTM) Chart

Syneos Health Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Owner Earnings per Share (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.41 1.91 3.09 3.19 3.21

Syneos Health Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Owner Earnings per Share (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.94 3.97 3.21 2.55 0.96

Competitive Comparison of Syneos Health's Owner Earnings per Share (TTM)

For the Diagnostics & Research subindustry, Syneos Health's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syneos Health's Price-to-Owner-Earnings Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Syneos Health's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Syneos Health's Price-to-Owner-Earnings falls into.



Syneos Health Owner Earnings per Share (TTM) Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

To make it simple, then you will have:

Owner Earnings per Share (TTM) = (Net Income + Depreciation, Depletion and Amortization + Change In Deferred Tax - 5Y Average of Maintenance Capital Expenditure + Change In Working Capital) / Shares Outstanding (Diluted Average)

Syneos Health's Owner Earnings per Share (TTM) Calculation:

TTM / Last Quarter Average of Last 20 Quarters
Net Income 71
Depreciation, Depletion and Amortization 245
Change In Deferred Tax -37
5Y Average of Maintenance Capital Expenditure 57
Change In Working Capital -123
Shares Outstanding (Diluted Average) 104

1. Start with "Net Income" from income statement. Syneos Health's Net Income for the trailing twelve months (TTM) ended in Jun. 2023 was $71 Mil.

2. "Depreciation, Depletion and Amortization" is from cashflow statement. Syneos Health's Depreciation, Depletion and Amortization for the trailing twelve months (TTM) ended in Jun. 2023 was $245 Mil. This needs to be added back because company does not actually need to pay cash for it. It is a non-cash item.

3. Other non-cash charges usually include "Stock Based Compensation" and "Change In Deferred Tax":
However, to be conservative, GuruFocus will not add Stock Based Compensation back to net income. Syneos Health's Change In Deferred Tax for the trailing twelve months (TTM) ended in Jun. 2023 was $-37 Mil.

4. Average maintenance capital expenditure over a business/industry cycle: 5-Year Average Maintenance Capital Expenditure = $57 Mil

It is usually best to take a long-term average of maintenance capital expenditure. Ideally this would be as long as 10 years and include at least one economic downturn. However, since many companies do not have as long as 10-year history, here GuruFocus uses the latest 5 years data to do the calculation. To smooth out unusual years but reflect recent developments, we take an average of the 5 year maintenance capital expenditure.

The following shows how to get maintenance capital expenditure.

First, calculate the revenue change regarding to the previous quarter. If the revenue decreased from the previous quarter, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
Second, if the revenue increased from the previous quarter, then calculate the percentage of Net PPE as of corresponding Revenue.
Growth Capital Expenditure = Percentage of Property, Plant and Equipment as of corresponding Revenue * Revenue Increase
Third, calculate Capital Expenditure (positive) - Growth Capital Expenditure.
If [Capital Expenditure (positive) - Growth Capital Expenditure] was negative, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
If [Capital Expenditure (positive) - Growth Capital Expenditure] was positive, then the Maintenance Capital Expenditure = Capital Expenditure (positive) - Growth Capital Expenditure.
Fourth, get the average of the 5 years maintenance capital expenditure.

Syneos Health's 5-Year Average Maintenance Capital Expenditure = $57 Mil

5. "Change In Working Capital" is from cashflow statement. Syneos Health's Change In Working Capital for the trailing twelve months (TTM) ended in Jun. 2023 was $-123 Mil.
Note: GuruFocus' Change in Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And sometimes it includes non-current parts of assets and liabilities.

6. Syneos Health's Shares Outstanding (Diluted Average) for the months ended in Jun. 2023 was 104.344 Mil.

Syneos Health's Onwer Earnings Per Share for Jun. 2023 is calculated as:

Owner Earnings per Share (TTM)
=( Net Income+Depreciation, Depletion and Amortization+Change In Deferred Tax
=( 71.221 +244.675+-36.697
-5Y Avg of Maintenance CAPEX+Change In Working Capital )/Shares Outstanding (Diluted Average)
-56.612847675456+-122.848)/104.344
=0.96

Price-to-Owner-Earnings=Current Price/Owner Earnings per Share (TTM)
=42.98/0.96
=44.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Assumption: Companies usually do not report maintenance capital expenditures and growth capital expenditures separately. Here we use estimated numbers and average them over 5 years. The method to estimate maintenance capital expenditures can be found in above part 4.

Note: GuruFocus' Change In Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And it includes non-current parts of assets and liabilities.


Syneos Health Owner Earnings per Share (TTM) Related Terms

Thank you for viewing the detailed overview of Syneos Health's Owner Earnings per Share (TTM) provided by GuruFocus.com. Please click on the following links to see related term pages.


Syneos Health (Syneos Health) Business Description

Traded in Other Exchanges
N/A
Address
1030 Sync Street, Morrisville, NC, USA, 27560-5468
Syneos is a global contract research and outsourced commercialization organization that provides services to pharmaceutical and biotechnology firms. Its clinical solutions segment offers early- to late-stage clinical trial support that ranges from specialized staffing models to strategic partnerships that oversee nearly all aspects of a drug program, while the company's commercialization solutions includes outsourced sales, consulting, public relations, and advertising services.
Executives
Michael J. Bonello officer: Chief Financial Officer 4130 PARKLAKE AVENUE, SUITE 400, RALEIGH NY 27612
Stanford Rudnick officer: See remarks C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560-5468
Christian Tucat officer: Chief Business Officer C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560-5468
Michael Lee Brooks officer: See remarks C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560
Jonathan Olefson officer: General Counsel & Corp Secty C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560
Michelle Keefe officer: Pres., Commercial Solutions C/O SYNEOS HEALTH,INC., 1030 SYNC STREET, MORRISVILLE NC 27560
Jason M. Meggs officer: Chief Financial Officer C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560
Donna Hildebrand Kralowetz officer: SVP, Chief Accounting Officer C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560
Matthew E. Monaghan director ONE INVACARE WAY, ELYRIA OH 44035
Alfonso G Zulueta director 4925 INDIANA AVE, LISLE IL 60532
Barbara W. Bodem director C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Linda S Harty director MEDTRONIC PLC, 710 MEDTRONIC PARKWAY NE, LC-150, MINNEAPOLIS MN 55432
Alistair Macdonald officer: Chief Operating Officer C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560
David S. Wilkes director ONE BAXTER PARKWAY, DEERFIELD IL 60015
Advent International Corp/ma 10 percent owner 800 BOYLSTON STREET SUITE 3300, BOSTON MA 02199

Syneos Health (Syneos Health) Headlines

From GuruFocus